Cisplatin-associated thrombosis.
Anticancer Drugs
; 19(9): 927-9, 2008 Oct.
Article
en En
| MEDLINE
| ID: mdl-18766008
The discovery of cisplatin has made arguably the biggest contribution to cancer medicine, providing the basis for the chemotherapy treatment of many malignancies. In addition to well-documented toxicities such as neurotoxicity, cisplatin-induced vascular toxicity is becoming an increasing concern, with some authors describing it in up to 12% of patients. Given the efficacy of cisplatin, vascular toxicity represents a significant survivorship issue. We describe different manifestations of cisplatin-associated thrombosis and its putative pathophysiology.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Trombosis
/
Cisplatino
/
Neoplasias de Células Germinales y Embrionarias
Tipo de estudio:
Risk_factors_studies
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Anticancer Drugs
Asunto de la revista:
ANTINEOPLASICOS
Año:
2008
Tipo del documento:
Article
Pais de publicación:
Reino Unido